Gainers
- Cyclerion Therapeutics CYCN stock rose 17.3% to $2.98 during Friday's pre-market session. The market value of their outstanding shares is at $8.0 million.
- Biodesix BDSX shares moved upwards by 16.34% to $1.21. The company's market cap stands at $175.6 million.
- Artiva Biotherapeutics ARTV shares rose 14.62% to $6.19. The market value of their outstanding shares is at $150.3 million.
- OS Therapies OSTX shares moved upwards by 13.33% to $2.21. The company's market cap stands at $46.9 million.
- Sera Prognostics SERA shares increased by 12.78% to $7.5. The company's market cap stands at $253.2 million.
- Valneva VALN stock moved upwards by 12.57% to $5.91. The market value of their outstanding shares is at $479.8 million.
Losers
- Scienture Holdings SCNX shares decreased by 25.1% to $2.92 during Friday's pre-market session. The market value of their outstanding shares is at $25.1 million.
- Aptorum Gr APM stock fell 17.89% to $1.01. The company's market cap stands at $5.5 million.
- NanoVibronix NAOV shares decreased by 13.58% to $0.51. The market value of their outstanding shares is at $3.1 million.
- Kazia Therapeutics KZIA shares decreased by 12.64% to $1.66. The market value of their outstanding shares is at $9.2 million.
- TruBridge TBRG stock declined by 10.17% to $22.1. The market value of their outstanding shares is at $329.8 million.
- Arcus Biosciences RCUS shares decreased by 9.5% to $12.11. The company's market cap stands at $1.1 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ARTVArtiva Biotherapeutics Inc
$6.1814.4%
BDSXBiodesix Inc
$1.2116.4%
CYCNCyclerion Therapeutics Inc
$2.8813.4%
KZIAKazia Therapeutics Ltd
$1.64-13.7%
NAOVNanoVibronix Inc
$0.5001-15.2%
OSTXOS Therapies Inc
$2.118.21%
RCUSArcus Biosciences Inc
$13.00-2.84%
SCNXScienture Holdings Inc
$2.92-25.1%
SERASera Prognostics Inc
$7.4912.6%
TBRGTruBridge Inc
$22.11-10.1%
VALNValneva SE
$5.9112.6%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in